Interleukin-10 responses to therapeutic vaccination during highly active antiretroviral therapy and after analytical therapy interruption.

Antzeko izenburuak

• Highly active antiretroviral therapy interruption: predictors and virological and immunologic consequences.
  nork: Touloumi, G, et al.
  Argitaratua: (2006)
• Therapeutic immunization of highly active antiretroviral therapy-treated HIV-1-infected patients: safety and immunogenicity of an HIV-1 gag/poly-epitope DNA vaccine.
  nork: Dorrell, L, et al.
  Argitaratua: (2005)
• TILT: a randomized controlled trial of interruption of antiretroviral therapy with or without interleukin-2 in HIV-1 infected individuals.
  nork: Angus, B, et al.
  Argitaratua: (2008)
• Antiretroviral therapy interruptions: impact on HIV treatment and transmission
  nork: Dubrocq G, et al.
  Argitaratua: (2018-06-01)
• Broad TCR usage in functional HIV-1-specific CD8+ T cell expansions driven by vaccination during highly active antiretroviral therapy.
  nork: Yang, H, et al.
  Argitaratua: (2007)